Zhangzhou Dadi Pharmaceutical Technology Co., Ltd.

Technical development, research and consulting services for pharmaceutical and chemical products; sales of irinotecan, diacerein, pramipexole, amisulpride, fluvalinate copper and regulic acid; import and export of goods (except for those restricted by laws and regulations, those that require a license shall operate with the license).
Business Type Manufacturer
Location ChinaZhejiangQuzhou
Year Established 2007-06-01
Total Employees 1
Total Annual Revenue -
Main Products 1,8-Naphthalic anhydride, 2-iodoacetamide, 4,6-dichloropyrimidine, 4,6-dihydroxypyrimidine, acetylacetone, imatinib, glycidol, gefitinib, pyrazine, tetrahydrothiophene, prasugrel, temozolomide, ethyl chloride, imatinib mesylate, diphenyl carbonate, glycidol, metadoxine, biphenyl, benzoate, amide, diazo
Main Market -